We are collecting data on people who have sought ibogaine treatment all around the world so we can start to collect a very ...

Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.

People who need emergency care or hospitalization for cannabis use disorder are at an elevated risk of premature death within ...

The New York State health department is underscoring the importance of addiction medication in ending the opioid crisis.

For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

Dexamphetamine—a restricted stimulant drug used to treat narcolepsy and Attention Deficient Hyperactivity Disorder ...

ALBANY — An investigation into a series of episodes in which state prison workers have been rushed to hospitals after ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so ...

Depressed drinkers experience alcohol’s pleasure and stimulation, challenging beliefs about self-medication and addiction.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.